This article has been reviewed according to Science X's editorial process and policies. Editors have highlighted the following attributes while ensuring the content's credibility:


peer-reviewed publication

trusted source


Previous smallpox vaccine shown to provide immunity to mpox

Previous smallpox vaccine provides immunity to mpox
Graphical abstract. Credit: Cell Host & Microbe (2023). DOI: 10.1016/j.chom.2023.04.015

Vaccines against smallpox given until the mid-1970s offer continuing cross-reactive immunity to mpox, researchers from Karolinska Institutet in Sweden report in a study published in Cell Host & Microbe.

During last year's mpox outbreak, the virus spread for the first time outside Africa, causing over 85,000 cases of the disease to date. Men who have sex with men account for the most infections, with a marked skew towards the young.

The virus that causes mpox is what is known as an orthopoxvirus and is very similar to the virus that caused smallpox until the mid-1970s when it was finally eradicated.

Long-lived memory cells

Since there were data indicating that the old could protect against mpox, the researchers at Karolinska Institutet wondered if the individuals who were vaccinated decades ago against the former would have some protection against the latter owing to a remaining memory response.

"Our study shows that this is the case, which implies that the are very long-lived and that they can recognize closely related viruses such as the mpox virus and provide overlapping, or cross-reactive immunity," says the study's corresponding author Marcus Buggert, docent and researcher at the Center for Infectious Medicine, Karolinska Institutet.

Significantly stronger immune response

By analyzing the T-cell immune response in 105 healthy blood donors, the researchers were able to show that individuals born before 1976 had a significantly stronger immune response against both viral types. The researchers also analyzed the immune response in 22 men with a recent mpox infection and showed that they also exhibited a strong to the , which may provide future immunity.

The current study was too small to judge how much protection previous smallpox vaccination provides, but Dr. Buggert refers to a recently published British observational study examining the effect of a smallpox vaccine given to risk-group males in 2022.

"This study shows that vaccine can provide about 80 percent protection against mpox," he says.

More information: Sarah Adamo et al, Memory profiles distinguish cross-reactive and virus-specific T cell immunity to mpox, Cell Host & Microbe (2023). DOI: 10.1016/j.chom.2023.04.015

Journal information: Cell Host & Microbe
Citation: Previous smallpox vaccine shown to provide immunity to mpox (2023, May 23) retrieved 14 June 2024 from
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Explore further

Mpox vaccine found to be protective by CDC


Feedback to editors